摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R,S)-methyl 3-methyl-2-{[(2E)-3-phenylprop-2-enoyl]amino}butanoate | 127750-57-6

中文名称
——
中文别名
——
英文名称
(R,S)-methyl 3-methyl-2-{[(2E)-3-phenylprop-2-enoyl]amino}butanoate
英文别名
N-cinnamoyl-D,L-valine methyl ester;methyl 3-methyl-2-[[(E)-3-phenylprop-2-enoyl]amino]butanoate
(R,S)-methyl 3-methyl-2-{[(2E)-3-phenylprop-2-enoyl]amino}butanoate化学式
CAS
127750-57-6
化学式
C15H19NO3
mdl
MFCD00706831
分子量
261.321
InChiKey
FPCRRVNOCVWNIW-MDZDMXLPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:337630b8be33179792a189072ec32003
查看

反应信息

  • 作为反应物:
    描述:
    (R,S)-methyl 3-methyl-2-{[(2E)-3-phenylprop-2-enoyl]amino}butanoate氢溴酸双氧水 作用下, 以 乙醇 为溶剂, 反应 0.58h, 生成 methyl N-(α, β-dibromo-β-phenylpropanoyl)valinate 、 methyl N-(α, β-dibromo-β-phenylpropanoyl)valinate
    参考文献:
    名称:
    N-肉桂酰氨基酸酰胺的超声辅助绿色溴化——结构表征和抗菌评价
    摘要:
    摘要 N-苯基丙烯酰基氨基酸酰胺已使用两种替代的声化学活化绿色化学程序进行溴化。第一个合成过程涉及在水性介质中使用离子液体作为反应催化剂的超声辅助溴化,而在第二个合成过程中,已经使用通过 H 2 O 2 氧化 HBr 原位形成 Br 2 。为了比较,还使用了传统的溴化程序。新溴化的化合物通过适当的分析技术进行表征。使用密度泛函理论 (DFT) 方法进行的详细 NMR 光谱分析和量子化学计算已用于定义产品的立体化学。结果证实了通过所采用的三种合成程序获得的产物的物理化学特性和相似的产率,并揭示了新合成产物的两种非对映异构形式的共存。评价了二溴化酰胺的抗菌和抗真菌活性。
    DOI:
    10.1016/j.molstruc.2017.01.056
  • 作为产物:
    描述:
    DL-缬氨酸甲酯盐酸盐3-苯基-2-丙烯酰氯potassium carbonate 作用下, 以 甲苯 为溶剂, 反应 0.33h, 以86%的产率得到(R,S)-methyl 3-methyl-2-{[(2E)-3-phenylprop-2-enoyl]amino}butanoate
    参考文献:
    名称:
    Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols
    摘要:
    Adequate control of seizures remains an unmet need in epilepsy. In order to identify new anticonvulsant agents, a series of N-trans-cinnamoyl derivatives of selected aminoalkanols was synthetized. The compounds were obtained in the reaction of N-acylation carried out in a two-phase system. The substances were tested in animal models of seizures induced either electrically (maximal electroshock - MES; 6-Hz test) or chemically, by subcutaneous injection of pentetrazol (scPTZ). Neurotoxicity was determined by the rotarod test. Lipophilicity of the active compounds, expressed as R-M0, was determined by reversed-phase thin layer chromatography and it ranged from 1.390 to 2.219. From among the tested series of compounds, R,S-(E)-N-(1-hydroxypropan-2-yl)-3-phenylprop-2-enamide (1) and R,S-(E)-N-(2-hydroxypropyl)-3-phenylprop-2-enamide (3) exhibited the best anticonvulsant activity. Compound 1, when administered to mice by intraperitoneal (i.p.) injection, showed the ED50 values of 86.6, 60.9, and 109.6 mg/kg in the MES, 6-Hz, and scPTZ tests, respectively. For compound 3, the ED50 values were found to be 47.1 mg/kg in MES and 77.1 mg/kg in scPTZ (mice, i.p.). The distances measured in crystals of compound 1 were: 7.99 angstrom - from the phenyl ring to the hydroxyl group in the amide moiety, 5.729 angstrom - from the phenyl ring to the amide group, and 3.112 angstrom - from the amide group to the hydroxyl group in the amide moiety. The reported compounds did not exhibit mutagenic potential when assayed in the Ames test. Compounds 1 and 3 did not affect viability and morphology of human hepatocellular carcinoma cells (HepG2). (C) 2015 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2015.10.051
点击查看最新优质反应信息

文献信息

  • Anti-Helicobacter pylori activities of selected N-substituted cinnamamide derivatives evaluated on reference and clinical bacterial strains
    作者:Karolina Klesiewicz、Elżbieta Karczewska、Paweł Nowak、Iwona Skiba-Kurek、Edward Sito、Katarzyna Pańczyk、Paulina Koczurkiewicz、Dorota Żelaszczyk、Elżbieta Pękala、Anna M. Waszkielewicz、Alicja Budak、Henryk Marona、Agnieszka Gunia-Krzyżak
    DOI:10.1038/s41429-018-0027-1
    日期:2018.5
    In this study, thirty-five N-substituted derivatives of cinnamic acid amide (cinnamamide) were evaluated for anti-Helicobacter pylori activity using an agar disc-diffusion method. Qualitative screening was performed on a reference H. pylori strain (ATCC 43504), resulting in the identification of the three most active compounds, 8 (R,S-(2E)-3-(4-chlorophenyl)-N-(2-hydroxypropyl)prop-2-enamide, minimal inhibitory concentration, MIC = 7.5 µg/mL), 23 ((2E)-3-(4-chlorophenyl)-N-(2-hydroxycyclohexyl)prop-2-enamide, MIC = 10 µg/mL), and 28 ((2E)-3-(4-chlorophenyl)-N-(4-oxocyclohexyl)prop-2-enamide, MIC = 10 µg/mL). These compounds were further tested on twelve well-characterized clinical strains, yielding MIC values that ranged from 10 to 1000 µg/mL. Preliminary safety assessments of the compounds were made using the MTT viability test for cytotoxicity and Ames test for mutagenicity, which showed them to be generally safe, although compounds 8 and 28 showed mutagenic activity at some of the tested concentrations. The results of this study showed the anti-H. pylori potential of cinnamamide derivatives.
    在本项研究中,使用琼脂平板扩散法对三十五种N-取代肉桂酸酰胺(肉桂酰胺)衍生物进行了抗幽门螺杆菌活性评估。通过对参考幽门螺杆菌菌株(ATCC 43504)的定性筛选,鉴定出三种最具活性的化合物,分别为8号(R,S-(2E)-3-(4-氯苯基)-N-(2-羟丙基)丙-2-烯酰胺,最小抑制浓度MIC=7.5μg/mL)、23号((2E)-3-(4-氯苯基)-N-(2-羟环己基)丙-2-烯酰胺,MIC=10μg/mL)和28号((2E)-3-(4-氯苯基)-N-(4-氧环己基)丙-2-烯酰胺,MIC=10μg/mL)。随后,这些化合物在十二种特征明确的临床菌株上进行了进一步测试,得到的MIC值范围从10到1000μg/mL不等。通过MTT活力度测试评估细胞毒性和Ames试验评估诱变性,对这些化合物进行了初步安全性评估,结果显示它们总体上是安全的,尽管在某些测试浓度下,8号和28号化合物表现出诱变活性。本研究结果表明,肉桂酰胺衍生物具有抗幽门螺杆菌的潜力。
  • Synthesis of pseudosparsomycins
    作者:A. A. Arutyunyan、R. G. Melik-Ogadzhanyan、L. G. Alaverdova、S. A. Papoyan、Yu. Z. Ter-Zakharyan、É. V. Kazaryan、G. M. Paronikyan、T. P. Sarkisyan
    DOI:10.1007/bf00764814
    日期:1989.10
  • ARUTYUNYAN, A. A.;MELIK-OGADZHANYAN, R. G.;ALAVERDOVA, L. G.;PAPOYAN, S. +, XIM.-FARMATS. ZH., 23,(1989) N0, S. 1223-1226
    作者:ARUTYUNYAN, A. A.、MELIK-OGADZHANYAN, R. G.、ALAVERDOVA, L. G.、PAPOYAN, S. +
    DOI:——
    日期:——
  • Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols
    作者:Agnieszka Gunia-Krzyżak、Ewa Żesławska、Karolina Słoczyńska、Paulina Koczurkiewicz、Wojciech Nitek、Dorota Żelaszczyk、Natalia Szkaradek、Anna M. Waszkielewicz、Elżbieta Pękala、Henryk Marona
    DOI:10.1016/j.ejmech.2015.10.051
    日期:2016.1
    Adequate control of seizures remains an unmet need in epilepsy. In order to identify new anticonvulsant agents, a series of N-trans-cinnamoyl derivatives of selected aminoalkanols was synthetized. The compounds were obtained in the reaction of N-acylation carried out in a two-phase system. The substances were tested in animal models of seizures induced either electrically (maximal electroshock - MES; 6-Hz test) or chemically, by subcutaneous injection of pentetrazol (scPTZ). Neurotoxicity was determined by the rotarod test. Lipophilicity of the active compounds, expressed as R-M0, was determined by reversed-phase thin layer chromatography and it ranged from 1.390 to 2.219. From among the tested series of compounds, R,S-(E)-N-(1-hydroxypropan-2-yl)-3-phenylprop-2-enamide (1) and R,S-(E)-N-(2-hydroxypropyl)-3-phenylprop-2-enamide (3) exhibited the best anticonvulsant activity. Compound 1, when administered to mice by intraperitoneal (i.p.) injection, showed the ED50 values of 86.6, 60.9, and 109.6 mg/kg in the MES, 6-Hz, and scPTZ tests, respectively. For compound 3, the ED50 values were found to be 47.1 mg/kg in MES and 77.1 mg/kg in scPTZ (mice, i.p.). The distances measured in crystals of compound 1 were: 7.99 angstrom - from the phenyl ring to the hydroxyl group in the amide moiety, 5.729 angstrom - from the phenyl ring to the amide group, and 3.112 angstrom - from the amide group to the hydroxyl group in the amide moiety. The reported compounds did not exhibit mutagenic potential when assayed in the Ames test. Compounds 1 and 3 did not affect viability and morphology of human hepatocellular carcinoma cells (HepG2). (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Ultrasound-assisted green bromination of N-cinnamoyl amino acid amides – Structural characterization and antimicrobial evaluation
    作者:Boyka Stoykova、Maya Chochkova、Galya Ivanova、Nadezhda Markova、Venelin Enchev、Iva Tsvetkova、Hristo Najdenski、Martin Štícha、Tsenka Milkova
    DOI:10.1016/j.molstruc.2017.01.056
    日期:2017.5
    Abstract N -phenylpropenoyl amino acid amides have been brominated using two alternative sonochemically activated green chemistry procedures. The first synthetic procedure has involved an ultrasound assisted bromination in an aqueous medium using ionic liquid as a catalyst of the reaction, whereas in the second one an in situ formation of Br 2 via oxidation of HBr by H 2 O 2 has been used. For comparison
    摘要 N-苯基丙烯酰基氨基酸酰胺已使用两种替代的声化学活化绿色化学程序进行溴化。第一个合成过程涉及在水性介质中使用离子液体作为反应催化剂的超声辅助溴化,而在第二个合成过程中,已经使用通过 H 2 O 2 氧化 HBr 原位形成 Br 2 。为了比较,还使用了传统的溴化程序。新溴化的化合物通过适当的分析技术进行表征。使用密度泛函理论 (DFT) 方法进行的详细 NMR 光谱分析和量子化学计算已用于定义产品的立体化学。结果证实了通过所采用的三种合成程序获得的产物的物理化学特性和相似的产率,并揭示了新合成产物的两种非对映异构形式的共存。评价了二溴化酰胺的抗菌和抗真菌活性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物